For 30% to 40% of lymphoma patients who receive CAR T therapy, the treatment is a godsend. Typically given to lymphoma patients for whom other treatments have proven ineffective, CAR T therapy involves removing immune cells ...
Apr 25, 2023
0
2
Pancreatic cancers are deadly and hard to treat, in part because they are so often detected at an advanced stage; overall five-year survival rates are about 11%. Two separate labs at Boston Children's Hospital took out-of-the-box ...
Apr 25, 2023
0
53
Scientists from the University of California, Irvine, the University of Michigan and the University of Texas MD Anderson Cancer Center have made a significant contribution to the field of pancreatic cancer research. Their ...
Apr 13, 2023
0
25
Scientists at VCU Massey Cancer Center discovered that the deletion of a specific protein creates a hostile environment for tumor cells and significantly subdues breast cancer growth and spread.
Apr 12, 2023
0
3
A new review paper was published in the journal Oncotarget on March 31, 2023, titled "Crosstalk between triple negative breast cancer and microenvironment."
Apr 11, 2023
0
5
A team has revealed the key mechanism of the loss of membrane protrusions on intratumoral natural killer (NK) cells, which impairs their ability to recognize and kill tumor cells, providing a new strategy for NK cell-based ...
Apr 10, 2023
0
39
A new editorial perspective titled "Cancer-associated fibroblasts: challenges and opportunities" has been published in Oncotarget.
Apr 5, 2023
0
0
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
New insights into a population of tumor-infiltrating T cells may ultimately allow doctors to predict how patients will respond to checkpoint blockade immunotherapy, a form of cancer treatment with advantages that doctors ...
A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in the initiation and progression of cancer.
Mar 31, 2023
0
6
